Use of smokeless tobacco by patients with drug-sensitive pulmonary tuberculosis: The need for strengthening tuberculosis–tobacco collaborative in India
The National Medical Journal of India · 2025
DOI: 10.25259/nmji_183_2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift The National Medical Journal of India, 2025. Verfasst von Antara Banik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Medicine, Government Medical College, Bhavnagar, Gujarat, India. Hauptthemen laut MEDLINE: Tobacco, Smokeless, Tuberculosis, Pulmonary. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
A joint tuberculosis–tobacco collaborative was launched in India in 2017 to reduce the addictive habit of tobacco use among patients with tuberculosis (TB). We aimed to estimate the prevalence and predictors of smokeless tobacco use and its awareness among patients with pulmonary TB in Bhavnagar city, Gujarat, India.
Methods
We did a cross-sectional study among 258 randomly selected drug-sensitive pulmonary TB patients registered at the District TB Centre in Bhavnagar from April to October 2019. The Global Adult Tobacco Survey questionnaire was used for data collection. Multivariable logistic regression was used to determine the predictors of smokeless tobacco use.
Results
Among the 258 patients, 73% were male, 66% were married, 40% traveled for their occupation, 62% had a nuclear family, and 46% were illiterate. More than half (52%) the patients used smokeless tobacco: 44% were daily users and 8% were occasional users. On multivariable logistic regression, male gender (adjusted odds ratio [aOR]: 5 [95% confidence interval (CI) 2–11]), occupation requiring travel (aOR: 4 [95% CI: 2–7]), monthly income of ₹3001–6000 (aOR: 0.2 [95% CI: 0.1–0.6]), ₹9000–12 000 (aOR: 0.3 [95% CI: 0.1–0.9]) and above ₹12 000 (aOR: 0.3 [95% CI: 0.1–0.8]) were significant predictors of smokeless tobacco use. Almost all (98%) of the participants were aware of the harmful effects of smokeless tobacco on health.
Conclusion
More than half the patients with pulmonary TB used smokeless tobacco. The TB–tobacco collaborative framework needs to be strengthened with brief counselling interventions for patients with TB using smokeless tobacco for collateral benefits in the control of TB in India.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Community Medicine, Government Medical College, Bhavnagar, Gujarat, India.
- Department of Respiratory Medicine, Government Medical College, Bhavnagar, Gujarat, India.
Zitieren
APA
Banik, A., Rupani, M. P., Trivedi, A. V., & Dave, J. D. (2025). Use of smokeless tobacco by patients with drug-sensitive pulmonary tuberculosis: The need for strengthening tuberculosis–tobacco collaborative in India. The National Medical Journal of India. https://doi.org/10.25259/nmji_183_2022
Vancouver
Banik A, Rupani MP, Trivedi AV, Dave JD. Use of smokeless tobacco by patients with drug-sensitive pulmonary tuberculosis: The need for strengthening tuberculosis–tobacco collaborative in India. The National Medical Journal of India. 2025. doi:10.25259/nmji_183_2022
BibTeX
@article{Banik2025,
author = {Banik, Antara and Rupani, Mihir P and Trivedi, Atulkumar V and Dave, Jigna D},
title = {Use of smokeless tobacco by patients with drug-sensitive pulmonary tuberculosis: The need for strengthening tuberculosis–tobacco collaborative in India},
journal = {The National Medical Journal of India},
year = {2025},
doi = {10.25259/nmji_183_2022}
}
EUVIMED